노스다코타의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 15개가 노스다코타 내 여러 지역에서 참여자를 모집하고 있습니다.
노스다코타의 도시
공식 연구 텍스트(영어)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04267848A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07293247A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Sanford Fargo Medical Center ( Site 3236), Fargo
- Altru Health System ( Site 3254), Grand Forks
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07513376Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford Broadway Medical Center, Fargo
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06498635A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0057), Fargo
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312137A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Research Site, Grand Forks
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06692738KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Sanford Fargo Medical Center ( Site 0039), Fargo
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04165070KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Sanford Fargo Medical Center ( Site 0039), Fargo
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04165798A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Sanford Fargo Medical Center ( Site 0039), Fargo
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06731907Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Sanford Roger Maris Cancer Center, Fargo
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 6. 26. 업데이트됨 · NCT04614103Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
피험자 모집 중2상
18 Minutes · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford Broadway Medical Center, Fargo
- 외 1개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06616584Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Essentia Health Cancer Center-South University Clinic, Fargo
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Fargo
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.